Puma Biotechnology Inc. | Mutual Funds
Mutual Funds that own Puma Biotechnology Inc.
SPDR S&P Biotech ETF
1,516,116
3.99%
3,900
1.13%
09/06/2018
Janus Research Fund
914,550
2.4%
-231,148
0.27%
06/30/2018
Vanguard Small Cap Index Fund
808,546
2.13%
10,908
0.04%
07/31/2018
Vanguard Total Stock Market Index Fund
798,376
2.1%
782
0.01%
07/31/2018
Janus Triton Fund
795,067
2.09%
129,873
0.3%
06/30/2018
Fidelity Select Biotechnology Portfolio
768,523
2.02%
-17,700
0.37%
07/31/2018
Government Pension Fund - Global (The)
687,687
1.81%
437,089
0%
12/31/2017
iShares Russell 2000 ETF
609,328
1.6%
-324
0.06%
09/06/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
467,300
1.23%
-59,400
0.88%
06/30/2018
Vanguard Small Cap Growth Index Fund
462,544
1.22%
8,074
0.08%
07/31/2018
| Address |
10880 Wilshire Boulevard
Los Angeles California 90024
United States
|
|
Employees
|
- |
| Website |
http://www.pumabiotechnology.com |
| Updated |
07/08/2019 |
| Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. |
